Copyright Reports & Markets. All rights reserved.

Global and United States Next Generation Implants (NGI) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Next Generation Implants (NGI) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Metals & Metal Alloys
    • 1.2.3 Ceramics
    • 1.2.4 Polymers
    • 1.2.5 Biologics
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Next Generation Implants (NGI) Market Share by Application: 2020 VS 2026
    • 1.3.2 Orthopedic Implants
    • 1.3.3 Cardiovascular Implants
    • 1.3.4 Ocular Implants
    • 1.3.5 Dental Implants
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Next Generation Implants (NGI) Market Perspective (2015-2026)
  • 2.2 Global Next Generation Implants (NGI) Growth Trends by Regions
    • 2.2.1 Next Generation Implants (NGI) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Next Generation Implants (NGI) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Next Generation Implants (NGI) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Next Generation Implants (NGI) Players by Market Size
    • 3.1.1 Global Top Next Generation Implants (NGI) Players by Revenue (2015-2020)
    • 3.1.2 Global Next Generation Implants (NGI) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Next Generation Implants (NGI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Next Generation Implants (NGI) Revenue
  • 3.4 Global Next Generation Implants (NGI) Market Concentration Ratio
    • 3.4.1 Global Next Generation Implants (NGI) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Next Generation Implants (NGI) Revenue in 2019
  • 3.5 Key Players Next Generation Implants (NGI) Area Served
  • 3.6 Key Players Next Generation Implants (NGI) Product Solution and Service
  • 3.7 Date of Enter into Next Generation Implants (NGI) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Implants (NGI) Breakdown Data by Type (2015-2026)

  • 4.1 Global Next Generation Implants (NGI) Historic Market Size by Type (2015-2020)
  • 4.2 Global Next Generation Implants (NGI) Forecasted Market Size by Type (2021-2026)

5 Next Generation Implants (NGI) Breakdown Data by Application (2015-2026)

  • 5.1 Global Next Generation Implants (NGI) Historic Market Size by Application (2015-2020)
  • 5.2 Global Next Generation Implants (NGI) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Next Generation Implants (NGI) Market Size (2015-2026)
  • 6.2 North America Next Generation Implants (NGI) Market Size by Type (2015-2020)
  • 6.3 North America Next Generation Implants (NGI) Market Size by Application (2015-2020)
  • 6.4 North America Next Generation Implants (NGI) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Next Generation Implants (NGI) Market Size (2015-2026)
  • 7.2 Europe Next Generation Implants (NGI) Market Size by Type (2015-2020)
  • 7.3 Europe Next Generation Implants (NGI) Market Size by Application (2015-2020)
  • 7.4 Europe Next Generation Implants (NGI) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Next Generation Implants (NGI) Market Size (2015-2026)
  • 8.2 China Next Generation Implants (NGI) Market Size by Type (2015-2020)
  • 8.3 China Next Generation Implants (NGI) Market Size by Application (2015-2020)
  • 8.4 China Next Generation Implants (NGI) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Next Generation Implants (NGI) Market Size (2015-2026)
  • 9.2 Japan Next Generation Implants (NGI) Market Size by Type (2015-2020)
  • 9.3 Japan Next Generation Implants (NGI) Market Size by Application (2015-2020)
  • 9.4 Japan Next Generation Implants (NGI) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Next Generation Implants (NGI) Market Size (2015-2026)
  • 10.2 Southeast Asia Next Generation Implants (NGI) Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Next Generation Implants (NGI) Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Next Generation Implants (NGI) Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Next Generation Implants (NGI) Introduction
    • 11.1.4 Abbott Laboratories Revenue in Next Generation Implants (NGI) Business (2015-2020))
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Arthrex
    • 11.2.1 Arthrex Company Details
    • 11.2.2 Arthrex Business Overview
    • 11.2.3 Arthrex Next Generation Implants (NGI) Introduction
    • 11.2.4 Arthrex Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.2.5 Arthrex Recent Development
  • 11.3 Biotronik SE & Co. KG
    • 11.3.1 Biotronik SE & Co. KG Company Details
    • 11.3.2 Biotronik SE & Co. KG Business Overview
    • 11.3.3 Biotronik SE & Co. KG Next Generation Implants (NGI) Introduction
    • 11.3.4 Biotronik SE & Co. KG Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.3.5 Biotronik SE & Co. KG Recent Development
  • 11.4 BOSTON SCIENTIFIC CORPORATION
    • 11.4.1 BOSTON SCIENTIFIC CORPORATION Company Details
    • 11.4.2 BOSTON SCIENTIFIC CORPORATION Business Overview
    • 11.4.3 BOSTON SCIENTIFIC CORPORATION Next Generation Implants (NGI) Introduction
    • 11.4.4 BOSTON SCIENTIFIC CORPORATION Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.4.5 BOSTON SCIENTIFIC CORPORATION Recent Development
  • 11.5 C. R. BARD, INC.
    • 11.5.1 C. R. BARD, INC. Company Details
    • 11.5.2 C. R. BARD, INC. Business Overview
    • 11.5.3 C. R. BARD, INC. Next Generation Implants (NGI) Introduction
    • 11.5.4 C. R. BARD, INC. Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.5.5 C. R. BARD, INC. Recent Development
  • 11.6 DANAHER CORPORATION
    • 11.6.1 DANAHER CORPORATION Company Details
    • 11.6.2 DANAHER CORPORATION Business Overview
    • 11.6.3 DANAHER CORPORATION Next Generation Implants (NGI) Introduction
    • 11.6.4 DANAHER CORPORATION Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.6.5 DANAHER CORPORATION Recent Development
  • 11.7 DENTSPLY SIRNA Inc.
    • 11.7.1 DENTSPLY SIRNA Inc. Company Details
    • 11.7.2 DENTSPLY SIRNA Inc. Business Overview
    • 11.7.3 DENTSPLY SIRNA Inc. Next Generation Implants (NGI) Introduction
    • 11.7.4 DENTSPLY SIRNA Inc. Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.7.5 DENTSPLY SIRNA Inc. Recent Development
  • 11.8 Edwards Lifesciences Corporation
    • 11.8.1 Edwards Lifesciences Corporation Company Details
    • 11.8.2 Edwards Lifesciences Corporation Business Overview
    • 11.8.3 Edwards Lifesciences Corporation Next Generation Implants (NGI) Introduction
    • 11.8.4 Edwards Lifesciences Corporation Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.8.5 Edwards Lifesciences Corporation Recent Development
  • 11.9 Globus Medical Inc.
    • 11.9.1 Globus Medical Inc. Company Details
    • 11.9.2 Globus Medical Inc. Business Overview
    • 11.9.3 Globus Medical Inc. Next Generation Implants (NGI) Introduction
    • 11.9.4 Globus Medical Inc. Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.9.5 Globus Medical Inc. Recent Development
  • 11.10 Integer Holdings Corporation
    • 11.10.1 Integer Holdings Corporation Company Details
    • 11.10.2 Integer Holdings Corporation Business Overview
    • 11.10.3 Integer Holdings Corporation Next Generation Implants (NGI) Introduction
    • 11.10.4 Integer Holdings Corporation Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 11.10.5 Integer Holdings Corporation Recent Development
  • 11.11 Integra LifeSciences Corporation
    • 10.11.1 Integra LifeSciences Corporation Company Details
    • 10.11.2 Integra LifeSciences Corporation Business Overview
    • 10.11.3 Integra LifeSciences Corporation Next Generation Implants (NGI) Introduction
    • 10.11.4 Integra LifeSciences Corporation Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 10.11.5 Integra LifeSciences Corporation Recent Development
  • 11.12 Institut Straumann AG
    • 10.12.1 Institut Straumann AG Company Details
    • 10.12.2 Institut Straumann AG Business Overview
    • 10.12.3 Institut Straumann AG Next Generation Implants (NGI) Introduction
    • 10.12.4 Institut Straumann AG Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 10.12.5 Institut Straumann AG Recent Development
  • 11.13 LifeNet Health, Inc.
    • 10.13.1 LifeNet Health, Inc. Company Details
    • 10.13.2 LifeNet Health, Inc. Business Overview
    • 10.13.3 LifeNet Health, Inc. Next Generation Implants (NGI) Introduction
    • 10.13.4 LifeNet Health, Inc. Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 10.13.5 LifeNet Health, Inc. Recent Development
  • 11.14 LivaNova PLC
    • 10.14.1 LivaNova PLC Company Details
    • 10.14.2 LivaNova PLC Business Overview
    • 10.14.3 LivaNova PLC Next Generation Implants (NGI) Introduction
    • 10.14.4 LivaNova PLC Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 10.14.5 LivaNova PLC Recent Development
  • 11.15 Novartis International AG
    • 10.15.1 Novartis International AG Company Details
    • 10.15.2 Novartis International AG Business Overview
    • 10.15.3 Novartis International AG Next Generation Implants (NGI) Introduction
    • 10.15.4 Novartis International AG Revenue in Next Generation Implants (NGI) Business (2015-2020)
    • 10.15.5 Novartis International AG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Next Generation Implants (NGI) Scope and Market Size
    Next Generation Implants (NGI) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Implants (NGI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Metals & Metal Alloys
    Ceramics
    Polymers
    Biologics
    Others

    Market segment by Application, split into
    Orthopedic Implants
    Cardiovascular Implants
    Ocular Implants
    Dental Implants

    Based on regional and country-level analysis, the Next Generation Implants (NGI) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Next Generation Implants (NGI) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Abbott Laboratories
    Arthrex
    Biotronik SE & Co. KG
    BOSTON SCIENTIFIC CORPORATION
    C. R. BARD, INC.
    DANAHER CORPORATION
    DENTSPLY SIRNA Inc.
    Edwards Lifesciences Corporation
    Globus Medical Inc.
    Integer Holdings Corporation
    Integra LifeSciences Corporation
    Institut Straumann AG
    LifeNet Health, Inc.
    LivaNova PLC
    Novartis International AG

    Buy now